Targeting ERK-MYD88 interaction leads to ERK dysregulation and immunogenic cancer cell death-Reference-Cited by-同舟云学术

Targeting ERK-MYD88 interaction leads to ERK dysregulation and immunogenic cancer cell death

Published:2024-08-15 Issue:1 Volume:15 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Virard François^ORCID,Giraud Stéphane,Bonnet Mélanie,Magadoux Léa,Martin Laetitia,Pham Thuy Ha,Skafi Najwa,Deneuve Sophie,Frem Rita,Villoutreix Bruno O.,Sleiman Nawal Hajj^ORCID,Reboulet Jonathan,Merabet Samir^ORCID,Chaptal Vincent^ORCID,Chaveroux Cédric,Hussein Nader,Aznar Nicolas,Fenouil Tanguy,Treilleux Isabelle,Saintigny Pierre,Ansieau Stéphane,Manié Serge^ORCID,Lebecque Serge,Renno Toufic,Coste Isabelle^ORCID

Funder

Ligue Contre le Cancer

Institut National Du Cancer

Fondation ARC pour la Recherche sur le Cancer

Agence Nationale de la Recherche

Pulsalys

Integrated Cancer Research Site LYriCAN (INCa-DGOS-Inserm_12563) Synergy Lyon Cancer Foundation

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41467-024-51275-z.pdf

Reference53 articles.

1. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646–674 (2011).

2. Coste, I. et al. Dual function of MyD88 in RAS signaling and inflammation, leading to mouse and human cell transformation. J. Clin. Invest. 120, 3663–3667 (2010).

3. Kfoury, A. et al. MyD88 in DNA repair and cancer cell resistance to genotoxic drugs. JNCI J. Natl. Cancer Inst. 105, 937–946 (2013).

4. Krivák, R. & Hoksza, D. P2Rank: machine learning based tool for rapid and accurate prediction of ligand binding sites from protein structure. J. Cheminform. 10, 39 (2018).

5. Liu, S., Sun, J.-P., Zhou, B. & Zhang, Z.-Y. Structural basis of docking interactions between ERK2 and MAP kinase phosphatase 3. Proc. Natl. Acad. Sci. USA 103, 5326–5331 (2006).